Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHOspholamban RElated CArdiomyopathy STudy - Intervention (Efficacy Study of Eplerenone in Presymptomaticphospholamban R14del Carriers)

NCT01857856 is registered in ClinicalTrials.gov with M.p. van den Berg, MD, PhD, professor in Cardiology as lead sponsor.

NCT NCT01857856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01857856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHOspholamban RElated CArdiomyopathy STudy - Intervention (Efficacy Study of Eplerenone in Presymptomaticphospholamban R14del Carriers)
Lead sponsor
M.p. van den Berg, MD, PhD, professor in Cardiology
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2013
Completion date
October 31, 2021
Enrollment
84 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

phospholamban r14del mutation-related cardiomyopathy